Literature DB >> 14534428

ApoE4 is more efficient than E3 in brain access by herpes simplex virus type 1.

Javier S Burgos1, Carlos Ramirez, Isabel Sastre, Maria J Bullido, Fernando Valdivieso.   

Abstract

Apolipoprotein E (ApoE) plays a relevant role in herpes simplex type 1 (HSV-1) infection of the CNS; after infection by the hematogenous route, the viral neuroinvasiveness directly depends on the APOE gene dose. To analyze the effect of ApoE isoforms on the HSV-1 infectivity to the brain, we have used a model of hematogenous infection of mice humanized for the ApoE3 or the ApoE4 alleles, and we have analyzed the presence of viral DNA in several organs by real time quantitative PCR. We have found that animals expressing human ApoE4 present very high levels of virus in the brain when compared to those expressing the ApoE3 allele; in contrast, there were no significant differences in the viral levels found in peripheral organs. Apolipoprotein E4 seems to facilitate the entry and/or spread of HSV-1 in the brain much more efficiently than E3, pointing to a novel potential mechanism underlying the susceptibility to neurodegenerative processes associated with the ApoE4 allele.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14534428     DOI: 10.1097/00001756-200310060-00013

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  29 in total

1.  Antiviral agents in Alzheimer's disease: hope for the future?

Authors:  Matthew A Wozniak; Ruth F Itzhaki
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

2.  Herpes simplex virus type 1 infection via the bloodstream with apolipoprotein E dependence in the gonads is influenced by gender.

Authors:  Javier S Burgos; Carlos Ramirez; Isabel Sastre; Juan M Alfaro; Fernando Valdivieso
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

Review 3.  Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?

Authors:  Lena J Al-Dujaili; Patrick P Clerkin; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Emily D Varnell; Herbert E Kaufman; James M Hill
Journal:  Future Microbiol       Date:  2011-08       Impact factor: 3.165

4.  Hematogenous vertical transmission of herpes simplex virus type 1 in mice.

Authors:  Javier S Burgos; Carlos Ramirez; Fernando Guzman-Sanchez; Juan M Alfaro; Isabel Sastre; Fernando Valdivieso
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

5.  Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA.

Authors:  Javier S Burgos; Carlos Ramirez; Isabel Sastre; Fernando Valdivieso
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

Review 6.  Can infections cause Alzheimer's disease?

Authors:  Francis Mawanda; Robert Wallace
Journal:  Epidemiol Rev       Date:  2013-01-24       Impact factor: 6.222

7.  Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1.

Authors:  Partha S Bhattacharjee; Donna M Neumann; Timothy P Foster; Saadallah Bouhanik; Christian Clement; Dass Vinay; Hilary W Thompson; James M Hill
Journal:  Exp Eye Res       Date:  2008-05-18       Impact factor: 3.467

8.  Changes in immunoglobulin levels related to herpes simplex virus type 1 brain infection in pregnant mice.

Authors:  Javier S Burgos; Carlos Ramirez; Anna Brachet; Juan M Alfaro; Isabel Sastre; Fernando Valdivieso
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

9.  Herpes simplex virus type 1 and Alzheimer's disease: the autophagy connection.

Authors:  Ruth F Itzhaki; S Louise Cosby; Matthew A Wozniak
Journal:  J Neurovirol       Date:  2008-01       Impact factor: 2.643

Review 10.  Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review.

Authors:  Inga Kuhlmann; Anne Marie Minihane; Patricia Huebbe; Almut Nebel; Gerald Rimbach
Journal:  Lipids Health Dis       Date:  2010-01-28       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.